✦ LIBER ✦

Choice of Conduit for the Right Coronary System: 8-Year Analysis of Radial Artery Patency and Clinical Outcomes Trial

✍ Scribed by Ignatius E. Hadinata; Philip A.R. Hayward; David L. Hare; George S. Matalanis; Siven Seevanayagam; Alexander Rosalion; Brian F. Buxton

Book ID: 116265114
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 513 KB
Volume: 88
Category: Article
ISSN: 0003-4975
DOI: 10.1016/j.athoracsur.2009.06.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conduit Choice for the Right Coronary Sy

Conduit Choice for the Right Coronary System: An 8-year Analysis from the Randomised RAPCO Trial

✍ Ignatius E. Hadinata; Philip A.R. Hayward; Brian F. Buxton; George S. Matalanis; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Comparable patencies of the radial arter

Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: Results from the Radial Artery Patency and Clinical Outcomes trial

✍ Mats Dreifaldt; Domingos S. Souza; Michael Richard Dashwood 📂 Article 📅 2010 🏛 CTSNet 🌐 English ⚖ 295 KB

Comparable patencies of the radial arter

Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: Results from the Radial Artery Patency and Clinical Outcomes trial

✍ Philip A.R. Hayward; Ian R. Gordon; David L. Hare; George Matalanis; Mark L. Hor 📂 Article 📅 2010 🏛 CTSNet 🌐 English ⚖ 283 KB

ANGIOGRAPHIC PATENCY OF CORONARY ARTERY

ANGIOGRAPHIC PATENCY OF CORONARY ARTERY GRAFTS: 5-YEAR OBSERVATIONAL DATA FROM THE RANDOMISED CONTROLLED ‘RADIAL ARTERY PATENCY AND CLINICAL OUTCOMES’ (RAPCO) STUDY

✍ Philip Hayward 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Radial Artery Versus Saphenous Vein as t

Radial Artery Versus Saphenous Vein as the Second Conduit in Coronary Artery Bypass Grafting—A Meta-Analysis of Trials Comparing Clinical Outcomes

✍ J.J.B. Edelman; T.D. Yan; M.K. Wilson; P.G. Bannon; M.P. Vallely 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB